Efficacy of traditional Ayurvedic formulation (Divya Melanogrit) in Leukoderma: a single arm, open label, observational study.

Patanjali Research Institute governed by Patanjali Research Foundation Trust0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1.Patients who are known cases of leukoderma (vitiligo).
•2.Age should be minimum of 18 years.
•3.Patient who is willing to participate voluntary and comply throughout the study process.
•4.Informed consent must be obtained

•CRITERIA FOR INCLUSION AND EXCLUSION
•Inclusion criteria
•1.Patients who are known cases of leukoderma (vitiligo).
•2.Age should be minimum of 18 years.
•3.Patient who is willing to participate voluntary and comply throughout the study process.
•4.Informed consent must be obtained.
•Exclusion criteria
•1.Patients who do not fulfill inclusion criteria must be excluded.
•2.Known cases of Psoriasis, eczema or any other skin allergies patients will be excluded.
•3.Patients who are currently undergoing any restricted therapy like UV phototherapy, Tar therapy, topical photo chemotherapy, oral and topical corticosteroids, immunomodulators, etc. will be excluded.
•4.Patients who are pregnant, lactating and those who plan to become pregnant within a year.
•5.Those with a history of primary cardiovascular, respiratory, digestive, urinary, endocrinological and haematological diseases that cannot be controlled with ordinary treatments will be excluded.
•6.Those with malignant diseases, infections, electrolyte imbalances and acid-base disturbances will be excluded.
•7.Patients who are allergic to any medicine or ingredients used in this study will be excluded.
•8.Patients who are consuming steroids during the study duration must be excluded.

发起方

Patanjali Research Institute governed by Patanjali Research Foundation Trust